Trends in Atopic Dermatitis Medication Utilization and Pharmacy Costs in Pediatric Commercial and Medicaid Populations and Utilization of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss and diabetes

Steven C Do, PharmD, Health Economics and Outcomes Research Fellow with VBPI, presented "Trends in Atopic Dermatitis Medication Utilization and Pharmacy Costs in Pediatric Commercial and Medicaid Populations" and "Utilization of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss and diabetes: a state-level analysis across payer types".